Valuation
- Market cap
- 53,595,000
- Revenue TTM
- $0
- Net income TTM
- $-9,160,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 2,100
- Avg volume
- 6,354
- Day's range
- $5.76 – $6.00
- Shares out
- 9,305,000
- Stochastic %K
- 1%
- Beta
- 3.19
- Analysts
- Strong Buy
- Price target
- —
Company profile
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 626 415 1488
- Website
- https://www.exozymes.com
- Address
- 750 Royal Oaks Drive, Suite 106, Monrovia, United States
Latest news
No headlines yet.
